Loading…
Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer
Background Clinical efficacy of aggressive end-of-life (EOL) chemotherapy remains unclear. Method Medical records of patients with advanced cancer between August 2011 and August 2016 were retrospectively analyzed. The primary endpoint was to identify prognostic factors at the last administration of...
Saved in:
Published in: | International journal of clinical oncology 2019-04, Vol.24 (4), p.454-459 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Clinical efficacy of aggressive end-of-life (EOL) chemotherapy remains unclear.
Method
Medical records of patients with advanced cancer between August 2011 and August 2016 were retrospectively analyzed. The primary endpoint was to identify prognostic factors at the last administration of chemotherapy. The secondary endpoint was to analyze the relationship between EOL symptoms and EOL treatment details.
Results
Among 300 evaluated patients, the number of patients who died within 14 and 30 days from the last administration of chemotherapy were 16 (5.3%) and 50 (16.7%), respectively. Multivariate analysis revealed that ECOG-PS (OR 3.698,
p
|
---|---|
ISSN: | 1341-9625 1437-7772 |
DOI: | 10.1007/s10147-018-1363-7 |